Hikurangi Cannabis inks multi-million dollar deal
But market supply deal is conditional on New Zealand legislation being passed.
Hikurangi Cannabis Company, a medical cannabis venture based in Ruatoria, has inked a multi-million dollar deal to produce medical-grade cannabis for the US market.
The company has signed a letter of intent with Seattle-based Rhizo Sciences to produce 3000kg of pharmaceutical-grade cannabis
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Fri, 23 Feb 2018
Fri, 23 Feb 2018
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Hikurangi Cannabis inks multi-million dollar deal
73565